Skip to main content
Erschienen in: Current Neurology and Neuroscience Reports 2/2011

01.04.2011

The Pathophysiologic Basis of Secondary Narcolepsy and Hypersomnia

verfasst von: Takashi Kanbayashi, Yohei Sagawa, Fumi Takemura, Sachiko-Uemura Ito, Ko Tsutsui, Yasuo Hishikawa, Seiji Nishino

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

The symptoms of narcolepsy can occur during the course of other neurologic conditions (ie, symptomatic narcolepsy). Inherited disorders, tumors, and head trauma were the three most frequent causes for symptomatic narcolepsy. Other causes include multiple sclerosis (MS), vascular disorders, and encephalitis. Cerebrospinal fluid hypocretin-1 measures were carried out in some recent cases with symptomatic narcolepsy, and moderate decreases in hypocretin levels were seen in a large majority of these cases. Excessive daytime sleepiness (EDS) in these symptomatic cases was sometimes reversible with an improvement of the causative neurologic disorder and with an improvement of the hypocretin (orexin) status. Recently, we found that several symptomatic narcoleptic cases with MS show unique bilateral symmetric hypothalamic lesions associated with significant hypocretin ligand deficiency. In addition, these patients often share the clinical characteristics of neuromyelitis optica (NMO) and the detection of NMO-IgG (or anti-aquaporin-4 [AQP4] antibodies), suggesting a new clinical entity. Further studies of the involvement of the hypocretin system in symptomatic narcolepsy and EDS are helpful to understand the pathophysiologic mechanisms for occurrence of EDS and cataplexy.
Literatur
1.
Zurück zum Zitat Nishino S, Kanbayashi T: Symptomatic narcolepsy, cataplexy, and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 2005, 9:269–310.PubMedCrossRef Nishino S, Kanbayashi T: Symptomatic narcolepsy, cataplexy, and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 2005, 9:269–310.PubMedCrossRef
2.
Zurück zum Zitat Ritchie C, Okuro M, Kanbayashi T, et al.: Hypocretin ligand deficiency in narcolepsy: recent basic and clinical insights. Curr Neurol Neurosci Rep. 2010 May;10(3):180–9.PubMedCrossRef Ritchie C, Okuro M, Kanbayashi T, et al.: Hypocretin ligand deficiency in narcolepsy: recent basic and clinical insights. Curr Neurol Neurosci Rep. 2010 May;10(3):180–9.PubMedCrossRef
3.
Zurück zum Zitat Verma A, Anand V, Verma NP: Sleep disorders in chronic traumatic brain injury. J Clin Sleep Med 2007, 3:357–362.PubMed Verma A, Anand V, Verma NP: Sleep disorders in chronic traumatic brain injury. J Clin Sleep Med 2007, 3:357–362.PubMed
4.
Zurück zum Zitat von Economo C: Encephalitis lethargica: its sequelae and treatment 1931. von Economo C: Encephalitis lethargica: its sequelae and treatment 1931.
5.
Zurück zum Zitat von Economo C: Sleep as a problem of localization. J Nerv Ment Dis 1930;71(3):249–59.CrossRef von Economo C: Sleep as a problem of localization. J Nerv Ment Dis 1930;71(3):249–59.CrossRef
6.
Zurück zum Zitat Mamelak M: A perspective on narcolepsy. Encephale 1992; 18(4):347–51.PubMed Mamelak M: A perspective on narcolepsy. Encephale 1992; 18(4):347–51.PubMed
7.
Zurück zum Zitat Siegel J: Brainstem mechanisms generating REM sleep. In: Kryger MR, Roth T, Roth T, Dement WC, editors. Principles and practice of sleep medicine. Philadelphia, PA: W.B. Saunders; 2000. p. 112–33. Siegel J: Brainstem mechanisms generating REM sleep. In: Kryger MR, Roth T, Roth T, Dement WC, editors. Principles and practice of sleep medicine. Philadelphia, PA: W.B. Saunders; 2000. p. 112–33.
8.
Zurück zum Zitat Aldrich M, Naylor M: Narcolepsy associated with lesions of the diencephalon. Neurology 1989;39(11):1505–8.PubMed Aldrich M, Naylor M: Narcolepsy associated with lesions of the diencephalon. Neurology 1989;39(11):1505–8.PubMed
9.
Zurück zum Zitat Nishino S, Ripley B, Overeem S, et al.: Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000, 355:39–40.PubMedCrossRef Nishino S, Ripley B, Overeem S, et al.: Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000, 355:39–40.PubMedCrossRef
10.
Zurück zum Zitat Peyron C, Faraco J, Rogers W, et al.: A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000, 6:991–997.PubMedCrossRef Peyron C, Faraco J, Rogers W, et al.: A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000, 6:991–997.PubMedCrossRef
11.
Zurück zum Zitat Thannickal T, Moore R, Nienhuis R, et al.: Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27(3):469–74.PubMedCrossRef Thannickal T, Moore R, Nienhuis R, et al.: Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27(3):469–74.PubMedCrossRef
12.
Zurück zum Zitat Scammell T, Nishino S, Mignot E, Saper C: Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke. Neurology 2001;56(12):1751–3.PubMed Scammell T, Nishino S, Mignot E, Saper C: Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke. Neurology 2001;56(12):1751–3.PubMed
13.
Zurück zum Zitat Marcus C, Mignot E: Letter to the editor regarding our previous publication: Secondary narcolepsy in children with brain tumors. Sleep 2002;25:435–9.PubMed Marcus C, Mignot E: Letter to the editor regarding our previous publication: Secondary narcolepsy in children with brain tumors. Sleep 2002;25:435–9.PubMed
14.
Zurück zum Zitat Nishino S, Kanbayashi T, Fujiki N, et al.: CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies. Neurology 2003, 61:823–825.PubMed Nishino S, Kanbayashi T, Fujiki N, et al.: CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies. Neurology 2003, 61:823–825.PubMed
15.
Zurück zum Zitat Overeem S, Dalmau J, Bataller L, et al.: Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology 2004;62(1):138–40.PubMed Overeem S, Dalmau J, Bataller L, et al.: Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology 2004;62(1):138–40.PubMed
16.
Zurück zum Zitat • Kanbayashi T, Shimohata T, Nakashima I, et al.: Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications. Arch Neurol 2009, 66(12):1563–1566. The authors report a significant recent study of symptomatic narcolepsy in patients diagnosed with immune-mediated neurologic condition MS with bilateral hypothalamic inflammatory lesions. The findings specifically link the presence of anti-AQP4 antibody and the probability of immune attack in hypothalamic periventricular regions to reduced CSF hypocretin-1 levels. Further, they suggest that additional antibody-mediated mechanisms also contribute to secondary hypocretin system impairment, manifesting in EDS symptoms.PubMedCrossRef • Kanbayashi T, Shimohata T, Nakashima I, et al.: Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications. Arch Neurol 2009, 66(12):1563–1566. The authors report a significant recent study of symptomatic narcolepsy in patients diagnosed with immune-mediated neurologic condition MS with bilateral hypothalamic inflammatory lesions. The findings specifically link the presence of anti-AQP4 antibody and the probability of immune attack in hypothalamic periventricular regions to reduced CSF hypocretin-1 levels. Further, they suggest that additional antibody-mediated mechanisms also contribute to secondary hypocretin system impairment, manifesting in EDS symptoms.PubMedCrossRef
17.
Zurück zum Zitat Poirier G, Montplaisir J, Dumont M, et al.: Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology 1987;37(4):693–5.PubMed Poirier G, Montplaisir J, Dumont M, et al.: Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology 1987;37(4):693–5.PubMed
18.
Zurück zum Zitat Ripley B, Fujiki N, Okura M, et al.: CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 2001, 57:2253–2258.PubMed Ripley B, Fujiki N, Okura M, et al.: CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 2001, 57:2253–2258.PubMed
19.
Zurück zum Zitat Tachibana N, Howar RS, Hirsch NP, et al.: Sleep problems in multiple sclerosis. Eur Neurol 1994, 34:320–323.PubMedCrossRef Tachibana N, Howar RS, Hirsch NP, et al.: Sleep problems in multiple sclerosis. Eur Neurol 1994, 34:320–323.PubMedCrossRef
20.
Zurück zum Zitat Amiry-Moghaddam M, Ottersen, OP: The molecular basis of water transport in the brain. Nat Rev Neurosci 2003, 4:991–1001.PubMedCrossRef Amiry-Moghaddam M, Ottersen, OP: The molecular basis of water transport in the brain. Nat Rev Neurosci 2003, 4:991–1001.PubMedCrossRef
21.
Zurück zum Zitat Pittock SJ, Weinshenker BG, Lucchinetti CF, et al.: Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006 Jul;63(7):964–8.PubMedCrossRef Pittock SJ, Weinshenker BG, Lucchinetti CF, et al.: Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006 Jul;63(7):964–8.PubMedCrossRef
22.
Zurück zum Zitat Lennon VA, Kryzer TJ, Pittock SJ, et al.: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202:473–477.PubMedCrossRef Lennon VA, Kryzer TJ, Pittock SJ, et al.: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202:473–477.PubMedCrossRef
23.
Zurück zum Zitat Nokura K, Kanbayashi T, Ozeki T, et al.: Hypersomnia secondary to hypothalamic damage and CSF Orexin-A level in four cases. Sleep 2004; 27(Suppl.):A249. Nokura K, Kanbayashi T, Ozeki T, et al.: Hypersomnia secondary to hypothalamic damage and CSF Orexin-A level in four cases. Sleep 2004; 27(Suppl.):A249.
24.
Zurück zum Zitat Tohyama J, Kanazawa O, Akasaka N, et al.: A case of bilateral paramedian thalamic infarction in childhood with the sensory disturbance and the sensory loss of taste. No To Hattatsu 2004;36(1):65–9.PubMed Tohyama J, Kanazawa O, Akasaka N, et al.: A case of bilateral paramedian thalamic infarction in childhood with the sensory disturbance and the sensory loss of taste. No To Hattatsu 2004;36(1):65–9.PubMed
25.
Zurück zum Zitat Guilleminault C, Quera-Salva M, Goldberg M: Pseudohypersomnia and pre-sleep behaviour with bilateral paramedian thalamic lesions. Brain 1993;116(6):1549–63.PubMedCrossRef Guilleminault C, Quera-Salva M, Goldberg M: Pseudohypersomnia and pre-sleep behaviour with bilateral paramedian thalamic lesions. Brain 1993;116(6):1549–63.PubMedCrossRef
26.
Zurück zum Zitat Bassetti C, Mathis J, Gugger M, et al.: Hypersomnia following paramedian thalamic stroke: a report of 12 patients. Ann Neurol 1996;39(4):471–80.PubMedCrossRef Bassetti C, Mathis J, Gugger M, et al.: Hypersomnia following paramedian thalamic stroke: a report of 12 patients. Ann Neurol 1996;39(4):471–80.PubMedCrossRef
Metadaten
Titel
The Pathophysiologic Basis of Secondary Narcolepsy and Hypersomnia
verfasst von
Takashi Kanbayashi
Yohei Sagawa
Fumi Takemura
Sachiko-Uemura Ito
Ko Tsutsui
Yasuo Hishikawa
Seiji Nishino
Publikationsdatum
01.04.2011
Verlag
Current Science Inc.
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 2/2011
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-011-0178-y

Weitere Artikel der Ausgabe 2/2011

Current Neurology and Neuroscience Reports 2/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.